4.8 Article

Bifunctional iminophosphorane catalysed enantioselective sulfa-Michael addition of alkyl thiols to alkenyl benzimidazoles

期刊

CHEMICAL SCIENCE
卷 9, 期 34, 页码 6969-6974

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c8sc01804a

关键词

-

资金

  1. EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/L015838/1]
  2. AstraZeneca
  3. Diamond Light Source
  4. Defence Science and Technology Laboratory
  5. Evotec
  6. GlaxoSmithKline
  7. Janssen
  8. Novartis
  9. Pfizer
  10. Syngenta
  11. Takeda
  12. UCB
  13. Vertex
  14. Universite Paris Descartes
  15. Spanish Ministry of Education, Culture and Sports
  16. National Science Foundation [ACI-1532235, ACI-1532236)]
  17. University of Colorado Boulder
  18. Colorado State University
  19. Extreme Science and Engineering Discovery Environment (XSEDE) [TG-CHE180006]

向作者/读者索取更多资源

The first enantioselective sulfa-Michael addition of alkyl thiols to alkenyl benzimidazoles, enabled by a bifunctional iminophosphorane (BIMP) organocatalyst, is described. The iminophosphorane moiety of the catalyst provides the required basicity to deprotonate the thiol nucleophile while the chiral scaffold and H-bond donor control facial selectivity. The reaction is broad in scope with respect to the thiol and benzimidazole reaction partners with the reaction proceeding in up to 98% yield and 96:4 er.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据